ロード中...
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial
BACKGROUND: CirCe01 trial aimed to assess the clinical utility of circulating tumour cell (CTC)-based monitoring in metastatic breast cancer (MBC) patients beyond the third line of chemotherapy (LC). METHODS: CirCe01 was a prospective, multicentre, randomised trial (NCT01349842) that included patien...
保存先:
| 出版年: | Br J Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8007590/ https://ncbi.nlm.nih.gov/pubmed/33473163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-01227-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|